Search for the latest oncology news by tumour type
FDA approves acalabrutinib with venetoclax for chronic lymphocytic leukeamia or small lymphocytic lymphoma
On February 19, 2026, the Food and Drug Administration approved acalabrutinib tablets and capsules in…